Suggests using sedative defined daily dose in critically ill patients, highlighting a need for standardized monitoring metrics.
TO THE EDITOR, We read with great interest the recent Research Letter by Noritomi et al. proposing the use of sedative defined daily dose (DDD) as a monitoring tool in critically ill patients.() The pursuit of standardized metrics to quantify sedative exposure is both timely and relevant, particularly in an era increasingly focused on sedation […]
No takes yet. Share an insight, caveat, or question.
Ferhan Demirer Aydemir (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: